Biomimetic DNA nanoballs for oligonucleotide delivery

Biomaterials

Volumn 62, Issue , 2015, Pages 155-163

  Kim, Mi Gyeong ^a   Park, Joo Yeon ^a   Shim, Gayong ^a   Choi, Han Gon ^b   Oh, Yu Kyoung ^a  

^a Seoul National University   (South Korea)

^b Hanyang University   (South Korea)

Author keywords

Antisense oligonucleotides; Biomimetic condensation; DNA nanoballs; Rolling circle amplification; Sequence specific loading

Indexed keywords

BIOMIMETICS; DNA; FLUORESCENCE; HYALURONIC ACID; MOBILE SECURITY; OLIGONUCLEOTIDES; PEPTIDES; TUMORS;

ANTICANCER EFFECTS; ANTISENSE OLIGONUCLEOTIDES; ANTITUMOR EFFECT; COMPLEMENTARY SEQUENCES; NANOBALLS; PROTEIN TARGETS; ROLLING CIRCLE AMPLIFICATIONS; SPECIFIC LOADING;

DNA SEQUENCES;

ANTISENSE OLIGONUCLEOTIDE; APATORSEN; BIOMIMETIC DNA NANOBALL; BIOMIMETIC MATERIAL; DOXORUBICIN; DZ 13; HERMES ANTIGEN; HYALURONIC ACID; MESSENGER RNA; NANOCARRIER; UNCLASSIFIED DRUG; COMPLEMENTARY DNA; NANOCAPSULE; NANOSPHERE;

ANTINEOPLASTIC ACTIVITY; ARTICLE; CONTROLLED STUDY; DNA HYBRIDIZATION; DNA TEMPLATE; DRUG DELIVERY SYSTEM; IN VITRO STUDY; IN VIVO STUDY; PRIORITY JOURNAL; PROTEIN EXPRESSION; TUMOR CELL; TUMOR LOCALIZATION; CELL SURVIVAL; CHEMISTRY; DIFFUSION; DRUG EFFECTS; GENE THERAPY; GENETIC TRANSFECTION; GENETICS; HUMAN; NEOPLASMS, EXPERIMENTAL; PARTICLE SIZE; PROCEDURES; SYNTHESIS; TREATMENT OUTCOME; TUMOR CELL LINE; ULTRASTRUCTURE;

ADENOVIRIDAE;

BIOMIMETIC MATERIALS; CELL LINE, TUMOR; CELL SURVIVAL; DIFFUSION; DNA, ANTISENSE; GENETIC THERAPY; HUMANS; NANOCAPSULES; NANOSPHERES; NEOPLASMS, EXPERIMENTAL; PARTICLE SIZE; TRANSFECTION; TREATMENT OUTCOME;

EID: 84930814120     PISSN: 01429612     EISSN: 18785905     Source Type: Journal    
DOI: 10.1016/j.biomaterials.2015.04.037     Document Type: Article

References (30)

1. Kole R., Krainer A.R., Altman S. RNA therapeutics: beyond RNA interference and antisense oligonucleotides. Nat. Rev. Drug Discov. 2012, 11:125-140.
2. Cai H., Santiago F.S., Prado-Lourenco L., Wang B., Patrikakis M., Davenport M.P., et al. DNAzyme targeting c-jun suppresses skin cancer growth. Sci. Transl. Med. 2012, 4:1-12.
3. Luvino D., Khiati S., Oumzil K., Rocchi P., Camplo M., Barthélémy P. Efficient delivery of therapeutic small nucleic acids to prostate cancer cells using ketal nucleoside lipid nanoparticles. J. Control Release 2013, 172:954-961.
4. Hadaschik B.A., Jackson J., Fazli L., Zoubeidi A., Burt H.M., Gleave M.E., et al. Intravesically administered antisense oligonucleotides targeting heat-shock protein-27 inhibit the growth of non-muscle-invasive bladder cancer. BJU Int. 2008, 102:610-616.
5. Tan M.L., Dunstan D.E., Friedhuber A.M., Choong P.F., Dass C.R. A nanoparticulate system that enhances the efficacy of the tumoricide Dz13 when administered proximal to the lesion site. J. Control Release 2010, 144:196-202.
6. Ballarín-González B., Howard K.A. Polycation-based nanoparticle delivery of RNAi therapeutics: adverse effects and solutions. Adv. Drug Deliv. Rev. 2012, 64:1717-1729.
7. Zhao W., Cui C.H., Bose S., Guo D., Shen C., Wong W.P. Bioinspired multivalent DNA network for capture and release of cells. Proc. Natl. Acad. Sci. U. S. A 2012, 109:19626-19631.
8. Hamblin G.D., Carneiro K.M., Fakhoury J.F., Bujold K.E., Sleiman H.F. Rolling circle amplification-templated DNA nanotubes show increased stability and cell penetration ability. J. Am. Chem. Soc. 2012, 134:2888-2891.
9. Lee J.B., Peng S., Yang D., Roh Y.H., Funabashi H., Park N., et al. A mechanical A mechanical metamaterial made from a DNA hydrogel. Nat. Nanotechnol. 2012, 7:816-820.
10. Lee J.B., Hong J., Bonner D.K., Poon Z., Hammond P.T. Self-assembled RNA interference microsponges for efficient siRNA delivery. Nat. Mater. 2012, 11:316-322.
11. Zhang Z., Ali M.M., Eckert M.A., Kang D.K., Chen Y.Y., Sender L.S. A polyvalent aptamer system for targeted drug delivery. Biomaterials 2013, 34:9728-9735.
12. Zöller M. CD44: can a cancer-initiating cell profit from an abundantly expressed molecule?. Nat Rev Cancer 2011, 11:254-267.
13. Elahy M., Dass C.R. Dz13: c-Jun downregulation and tumour cell death. Chem. Biol. Drug Des. 2011, 78:909-912.
14. Baylot V., Andrieu C., Katsogiannou M., Taieb D., Garcia S., Giusiano S., et al. OGX-427 inhibits tumor progression and enhances gemcitabine chemotherapy in pancreatic cancer. Cell Death Dis. 2011, 2:e221.
15. Park E., Kang H., Kim J., Ko J. The role of sLZIP in transcriptional regulation of c-Jun and involvement in migration and invasion of cervical cancer cells. Cell Physiol. Biochem. 2014, 33:151-164.
16. Huang C.C., Wang J.M., Kikkawa U., Mukai H., Shen M.R., Morita I., et al. Calcineurin-mediated dephosphorylation of c-Jun Ser-243 is required for c-Jun protein stability and cell transformation. Oncogene 2008, 27:2422-2429.
17. Dobo C., Stavale J.N., Lima Fde O., Ribeiro D.A., Arias V., Gomes T.S., et al. HSP27 is commonly expressed in cervical intraepithelial lesions of Brazilian women. Asian Pac. J. Cancer Prev. 2013, 14:5007-5010.
18. Jarvius J., Melin J., Göransson J., Stenberg J., Fredriksson S., Gonzalez-Rey C., et al. M.Digital quantification using amplified single molecule detection. Nat. Methods 2006, 3:725-727.
19. Huang S., Chen Y. Polymeric sequence probe for single DNA detection. Anal. Chem. 2011, 83:7250-7254.
20. Rajagopalan R., Xavier J., Rangaraj N., Rao N.M., Gopal V. Recombinant fusion proteins TAT-Mu, Mu and Mu-Mu mediate efficient non-viral gene delivery. J. Gene Med. 2007, 9:275-286.
21. Saccardo P., Villaverde A., Gonzalez-Montalban N. Peptide-mediated DNA condensation for non-viral gene therapy. Biotechnol. Adv. 2009, 27:432-438.
22. Mok H., Park J.W., Park T.G. Antisense oligodeoxynucleotide-conjugated hyaluronic acid/protamine nanocomplexes for intracellular gene inhibition. Bioconjug. Chem. 2007, 18:1483-1489.
23. Miao W., Shim G., Kang C.M., Lee S., Choe Y.S., Choi H.G., et al. Cholesteryl hyaluronic acid-coated, reduced graphene oxide nanosheets for anti-cancer drug delivery. Biomaterials 2013, 34:9638-9647.
24. Mo R., Jiang T., DiSanto R., Tai W., Gu Z. ATP-triggered anticancer drug delivery. Nat. Commun. 2014, 5:1-10.
25. Yao L., Wang Y., Xu S. Label-free microRNA detection based on exchange-induced remnant magnetization. Chem. Commun. 2013, 49:5183-5185.
26. Shinoda C., Maruyama M., Fujishita T., Dohkan J., Oda H., Shinoda K., et al. Doxorubicin induces expression of multidrug resistance-associated protein 1 in human small cell lung cancer cell lines by the c-jun N-terminal kinase pathway. Int. J. Cancer 2005, 117:21-31.
27. Hansen R.K., Parra I., Lemieux P., Oesterreich S., Hilsenbeck S.G., Fuqua S.A. Hsp27 overexpression inhibits doxorubicin-induced apoptosis in human breast cancer cells. Breast Cancer Res. Treat. 1999, 56:187-196.
28. Dass C.R., Khachigian L.M., Choong P.F. c-Jun knockdown sensitizes osteosarcoma to doxorubicin. Mol. Cancer Ther. 2008, 7:1909-1912.
29. Díaz-Chávez J., Fonseca-Sánchez M.A., Arechaga-Ocampo E., Flores-Pérez A., Palacios-Rodríguez Y., Domínguez-Gómez G., et al. Proteomic profiling reveals that resveratrol inhibits HSP27 expression and sensitizes breast cancer cells to doxorubicin therapy. PLoS One 2013, 8:e64378.
30. Li S.-D., Howell S.B. CD44-targeted microparticles for delivery of cisplatin to peritoneal metastases. Mol. Pharm. 2010, 7:280-290.